To earn CME related to this news article, click here. January 28, 2009 — Prolonged use, but not ever-use, of loop diuretics is linked to a higher fracture risk in postmenopausal women, according to ...

Research suggests that taking the blockbuster weight loss drug Wegovy (semaglutide) can help heart failure patients reduce their need for diuretics. Photo courtesy of Novo Nordisk People with heart ...

Starting dapagliflozin (Farxiga) early during acute heart failure hospitalization didn't boost decongestion, although it appeared to spare loop diuretic doses and increase diuresis compared with usual ...

Study finds no significant difference in hospitalization and death rates between patients who had a loop diuretic prescription at the time of peritoneal dialysis vs those who did not. Loop diuretic ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — A treatment strategy of torsemide vs. furosemide did not improve long-term clinical outcomes for ...

Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction ...

Dapagliflozin (Farxiga) appears to be no more effective than the "thiazide-like" diuretic metolazone at improving pulmonary congestion and fluid status in patients with acute heart failure (AHF), ...

For patients with chronic heart failure (HF) who have persistent congestion despite high doses of oral loop diuretics, the right way to intensify diuretics in the outpatient setting may be narrowed, ...

Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction ...

Please provide your email address to receive an email when new articles are posted on . Compared with placebo, Wegovy improved HF symptoms and physical limitations in patients with obesity-related ...